OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Cardiology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Knowing More Than the Knowns in Familial Hypercholesterolemia	434
Error in Table 1	264
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	259
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	253
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	221
Primary Prevention Management of Elevated Lipoprotein(a)	219
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	205
A Woman With Recurrent Torsade de Pointes	192
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	174
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	171
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	170
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	165
Chest Pain in a Middle-Aged Man	164
Genome-Wide Association Study of Accessory Atrioventricular Pathways	155
USPSTF Report on Aspirin for Primary Prevention	154
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	152
JAMA Cardiology	144
JAMA Cardiology	142
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals	142
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	132
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	131
Accountable Care Organization Participation and Cardiovascular Care Quality	128
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	124
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	120
Midlife Wealth Mobility and Long-term Cardiovascular Health	118

Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	115
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	114
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	112
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	111
JAMA Cardiology	109
What Is Your Secret to Health?	107
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	102
Supraventricular Tachycardia Following Mitral Valve Surgery	99
Assessing Performance of Machine Learning—Reply	98
JAMA Cardiology	95
JAMA Cardiology—The Year in Review, 2020	95
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	94
Hypertriglyceridemia in the MESA Study—Reply	91
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	87
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	87
Contribution of Clinical Trial Event Data by Data Source	86
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	84
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	81
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	81
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	79
Transthyretin Cardiac Amyloidosis in the Elderly—Tip of a Heart Failure Iceberg?	77
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	76
Innovation in Event Adjudication—Human vs Machine	76
Peak Oxygen Uptake vs Ventilatory Efficiency	73
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker	69
Identification of Cardiac Fibrosis in Young Adults With a Homozygous Frameshift Variant in SERPINE1	69
Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels	69
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	69
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	68
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	68
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	68
Is the Left Ventricular Ejection Fraction Measurement Still Preeminent?—New Measures to Quantify Subclinical Systolic Dysfunction	68
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	68
Corrected to Open Access Status	67
Change to Open Access Status	67
Genetic Studies of Atrial Fibrillation in Diverse Cohorts and Identification of Diverse Phenotypes Associated With Single Genes	66
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States	66
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	66
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1	66
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US	64
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection	62
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	61
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	61
Remote Postdischarge Treatment of Patients With Acute Myocardial Infarction by Allied Health Care Practitioners vs Standard Care	60
Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation	60
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors	59
Association of Complement and MAPK Activation With SARS-CoV-2–Associated Myocardial Inflammation	59
Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis	57
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	57
JAMA Cardiology	56

Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply	55
Young Man With Coarctation of the Aorta	54
To Be or Not to Be a CaMKII Inhibitor?	54
Error in Figure	54
JAMA Cardiology	53
An Expanded Heart Failure Indication for Sacubitril/Valsartan	52
Estimated Prevalence of Masked Asleep Hypertension in US Adults	51
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US	51
Exercise Capacity in Young Adults Born Small for Gestational Age	50
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality	50
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	49
Epicardial and Pericardial Fat—Separated But Under the Same Roof—Reply	49
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk	48
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	48
A Woman With Syncope and Frequent Premature Ventricular Contractions	47
To DOAC or Not to DOAC for Left Ventricular Thrombi—What Is the Dose?—Reply	47
Passing the Stethoscope	47
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	47
Transthyretin Genetic Testing	47
JAMA Cardiology	47
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events	47
To Occlude or Not to Occlude the Left Atrial Appendage in Women	47
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History	46
Importance of Prolonged QRS Duration in Detecting Complete Conduction Block	46
The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees	46
Exercise and Resistant Hypertension—Is Exercise Enough?—Reply	46
When Is a Placebo Not a Placebo	46
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure	46
Error in Figure 1	45
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US	45
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action	44
Troponins and Pregnancy—Reply	44
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi	44
Error in Abstract and Results	44
High-Sensitivity Troponin T and I Among Pregnant Women in the US—The National Health and Nutrition Examination Survey, 1999-2004	44
The Politics of HFpEF—What’s Good for the Left Is Good for the Right	44
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction	43
Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications	43
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity	42
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	42
Athletes With Cardiovascular Disease and Competitive Sports Eligibility	42
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019	42
Derivation and Validation of a 4-Level Clinical Pretest Probability Score for Suspected Pulmonary Embolism to Safely Decrease Imaging Testing	40
Early Mortality in Type A Acute Aortic Dissection	39
Prioritizing the Exposome to Reduce Cardiovascular Disease Burden	39
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease	39
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	39
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	38
A Patient in Their 30s With Dyspnea and a Spongy Heart	37
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	37
Personalizing Risk for Sudden Cardiac Death Among Patients With Dilated Cardiomyopathies	37
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	37
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One	36
An Elderly Woman With Ventricular Tachycardia	36
A 65-Year-Old Woman With Dyspnea and Recurrent Abdominal Distension	36
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?	36
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention	36
Incidental Complication From a Left Atrial Appendage Device	35
Expanding Discovery in Cardiovascular Genome-Wide Association Studies	35
Myocardial Infarction and Evolocumab	35
In Honor of the Pig	34
JAMA Cardiology	34
My Grandfather’s Blueprint	34
JAMA Cardiology	34
JAMA Cardiology	34
Error in Table	33
Corrected to Open Access Status	33
Errors in Key Points, Abstract, Results, and Figures	33
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure	33
Error in Abstract	33
Errors in Author Affiliations and Open Access Updated	33
Reflections of an Editorial Fellow—A Window Into Medical Publishing	33
The Growing Case for Routine Collection of Patient-Reported Outcomes	32
Indication Creep in Transcatheter Aortic Valve Implantation—Data or Desire?	31
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure	31
Association of Non–High-Density Lipoprotein Cholesterol Measured in Adolescence, Young Adulthood, and Mid-Adulthood With Coronary Artery Calcification Measured in Mid-Adulthood	31
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors	31
Preventing Declines in Cardiovascular Health From Childhood	31
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy	31
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality	31

State of the Nation’s Cardiovascular Health and Targeting Health Equity in the United States	31
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	30
What Role for New York Heart Association Class in Heart Failure Clinical Trials?	30
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017	30
Bizarre Wide-Complex Tachycardia in a Man in His 60s With Severe Chest Pain	30
Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model—Reply	30
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV	30
Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk	30
Error in Corresponding Author Information	30
A Man in His 60s With Severe Heart Failure and Incessant Ventricular Arrhythmias	29
Moving Beyond Conventional Guesstimation to Guide PCI	29
Updated USPSTF Guidelines for Screening for Atrial Fibrillation	29
Medicine, Writing, and the Limits of Language	29
Dapagliflozin—Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine?	29
JAMA Cardiology	29
A Young Woman With Dyspnea During Cardiac Catheterization	29
Medical Editors vs Nuclear Weapons—Is the Pen Mightier Than the Sword?	29
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk	28
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	28
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019	28
High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism	28
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement	28
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures	27
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock	27
Fontan Junctional Rhythm—Innocent Bystander or Silent Killer?	27
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	27
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes	27
Prevalence and Trends of Coronary Heart Disease in the United States, 2011 to 2018	27
Troubleshooting CardioMEMS After Implant—Failure to Read	26
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	26
JAMA Cardiology	26
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	26
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	25
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	25
To Occlude or Not to Occlude the Left Atrial Appendage in Women—Reply	25
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	24
A Teenager With Palpitations	24
Patient Enrollment for Cardiovascular Clinical Trials in the United States	24
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	24
A Man in His 60s With Pneumonia and Multiple Reintubation Attempts	24
The Fine Art and Science of Translating Trials Results Into Clinical Practice	23
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	23
Role of Income-Lifting Social Programs in Reducing Years of Life Lost to Myocardial Infarction and Sudden Death	23
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial	23
JAMA Cardiology	23
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	23
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	23
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	22
Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging	22
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	22
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	22
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	22
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	22
Association of Circulating Monocyte Chemoattractant Protein–1 Levels With Cardiovascular Mortality	22
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	22
A Simplified Method for the Diagnosis of Constrictive Pericarditis in the Cardiac Catheterization Laboratory	22
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	22
Authenticity—An Uphill Battle for a Black Woman in Cardiology	21
Clinical Utility of Lipoprotein(a) for Screening Does Not Determine Clinical Utility of Lipoprotein(a) for the Patient	21
Blood Pressure Control After SPRINT—Back to Reality	21
Persistent Opioid Use May Be a Failure of Pain Management Rather Than Prescribing	21
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?—Reply	21
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target	21
Transient Monocular Blindness in a Man in His 30s	21
Error in Affiliations	21
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	21
Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery	20
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery	20
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension	20
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	20
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation	20
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer	20
Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events	20
Private Equity and Cardiovascular Health Care	20
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis	20
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis	20
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation	20
Variants at the Interleukin 1 Gene Locus and Pericarditis	19
Women’s Representation in Interventional Cardiology	19
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients	19
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	19
Association of Financial Hardship Because of Medical Bills With Adverse Outcomes Among Families of Children With Congenital Heart Disease	19
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020	19
Educational Attainment and Lifetime Risk of Cardiovascular Disease	19
Reducing the Risks of Nuclear War—The Role of Health Professionals	18
Long-term Survival After Out-of-Hospital Cardiac Arrest	18
Error in the First Paragraph	18
Omitted Affiliation	18
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery	18
Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy	18
Recommendations for Deferred Testing in Low-Risk Chest Pain—Decades Old But Now Finally Tested	18
Genetic Testing in Early-Onset Atrial Fibrillation	18
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV	17
Heart Failure—Together We Go Farther—Reply	17